Acrivon Therapeutics, Inc 10-K for FY2022
Acrivon Therapeutics, Inc. (ACRV)
10-K
2023-03-28
For: 2022-12-31
View Original
Added on
April 07, 2026
About this 10-K
Acrivon Therapeutics, Inc filed this 10-K on March 28, 2023, covering the fiscal year ended December 31, 2022 (FY2022).
Headline figures
Fiscal year ended December 31, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Net loss
- $31.17M
- compared with a net loss of $16.24M a year earlier
- Diluted EPS
- -$7.56
- compared with -$9.32 a year earlier